Stocktoria
Co-Diagnostics, Inc. CODX
Co-Diagnostics, Inc. financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $622,489 | $3.9M | $6.8M | $34.2M | $97.9M | $74.6M | $214,974 | $39,911 | $7,662 | — |
| Gross profit | $400,112 | $2.9M | $2.6M | $28.7M | $86.3M | $58.0M | $102,543 | $30,520 | $7,360 | — |
| R&D expense | $19.1M | $21.0M | $23.0M | $17.4M | $15.0M | $3.2M | $1.4M | $1.4M | $1.0M | $731,474 |
| Operating income | -$50.2M | -$40.1M | -$42.7M | -$27.0M | $46.1M | $41.7M | -$5.9M | -$6.1M | -$4.6M | -$1.7M |
| Interest expense | — | — | — | — | — | — | $106,437 | — | $310,233 | $240,720 |
| Income tax | -$1.6M | $57,368 | -$2.8M | -$4.6M | $9.0M | $90,536 | — | — | — | — |
| Net income | -$46.9M | -$37.6M | -$35.3M | -$14.2M | $36.7M | $42.5M | -$6.2M | -$6.3M | -$7.0M | -$1.9M |
| EPS (diluted) | $-35.25 | $-37.22 | $-1.20 | $-0.45 | $1.23 | $1.52 | $-0.37 | — | — | — |
| Operating cash flow | -$29.1M | -$29.2M | -$22.1M | $6.6M | $41.1M | $28.2M | -$5.5M | -$4.1M | -$3.2M | -$1.3M |
| Free cash flow | -$29.8M | -$29.9M | -$23.4M | $5.1M | $40.4M | $27.4M | -$5.6M | -$4.1M | -$3.3M | -$1.3M |
| Cash & equivalents | $11.9M | $2.9M | $14.9M | $23.0M | $88.6M | $43.0M | $893,138 | $950,237 | $3.5M | $998,737 |
| Inventory | $992,397 | $1.1M | $1.7M | $5.3M | $2.0M | $8.0M | $197,168 | $18,153 | $9,068 | — |
| Total assets | $24.7M | $63.6M | $95.3M | $123.1M | $160.0M | $71.2M | $2.2M | $1.6M | $4.7M | $1.3M |
| Total liabilities | $4.1M | $9.7M | $9.3M | $8.6M | $25.6M | $4.5M | $478,070 | $2.6M | $811,802 | $4.3M |
| Shareholders' equity | $20.6M | $53.9M | $85.6M | $114.5M | $134.5M | $66.7M | $1.7M | -$1.1M | $3.9M | -$3.0M |
Growth · year-over-year · Revenue CAGR 73.3%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | -84.1% | -42.5% | -80.1% | -65.0% | +31.3% | +34579.9% | +438.6% | +420.9% | — | — |
| Net income growth | — | — | — | -138.8% | -13.7% | — | — | — | — | — |
| EPS growth | — | — | — | -136.6% | -19.1% | — | — | — | — | — |
| Free cash flow growth | — | — | -556.1% | -87.3% | +47.5% | — | — | — | — | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.